Shahriar Shalikar

Mr. Shahriar Shalikar

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SLSiqin Liu
Siqin Liu
OLOumaima Laghzali
Oumaima Laghzali
SSShahriar Shalikar
Shahriar Shalikar
MRMara-Camelia Rusu
Mara-Camelia Rusu
LCLucie Carrier
Lucie Carrier
MKMin-Chi Ku
Min-Chi Ku
Hypertrophic cardiomyopathy (HCM) is often characterized by augmented cardiac contractility, which frequently remains undetectable in its early stages. Emerging evidence suggests that hypercontractility is linked to mitochondrial defects that develop early in HCM progression. However, imaging markers for identifying these early alterations in myocardial function are lacking. We used cardiac magnetic resonance feature tracking (CMR-FT) to assess myocardial strain in a Mybpc3-knockin (KI) mouse model that mimicked human HCM. While homozygous (HOM) mice exhibited cardiac hypertrophy, heterozygous (HET) mice represented an early, asymptomatic stage of HCM. To explore mitochondrial contributions to hypercontractility, we evaluated mitochondrial integrity via scanning electron microscopy (SEM) and correlated these findings with strain abnormalities. Young HET female, but not male mice exhibited significant torsion abnormalities (p = 0.02), reduced left ventricular global longitudinal strain (LVGLS, p = 0.009), and impaired right ventricular global longitudinal strain (RVGLS, p = 0.035) compared to the controls. Strain abnormalities correlated strongly with mitochondrial morphological alterations, including changes in volume and area distribution (R > 0.7). Abnormal myocardial strain patterns, including torsion and GLS, serve as early markers of HCM and are closely associated with underlying mitochondrial dysfunction. The HET Mybpc3-KI HCM model provides important insights into the initial stages of HCM progression, highlighting strain abnormalities and sex-specific differences to enhance early diagnosis and therapeutic strategies.

19 November 2025 in JACC: Advances
Verified
Journal Article
Open access
OLOumaima Laghzali
Oumaima Laghzali
DKDanielle Kara
Danielle Kara
SCShi Chen
Shi Chen
SLSiqin Liu
Siqin Liu
SSShahriar Shalikar
Shahriar Shalikar
CNChristopher Nguyen
Christopher Nguyen
Hypertrophic cardiomyopathy (HCM) diagnosis often occurs after myocardium thickening develops, delaying intervention. Cardiac diffusion tensor imaging (cDTI) detects microstructural myocardial remodeling, offering potential for improved risk stratification, especially in patients with preserved ejection fraction. The objective of the study was to determine whether cDTI-derived fractional anisotropy (FA), mean diffusivity, and helix angle (HA) identify myocardial disarray and structural remodeling in HCM in patients and in mouse models. Cardiovascular magnetic resonance imaging at 3T with cDTI (FA, mean diffusivity, and HA) and cine imaging was performed in 10 HCM patients with prior late gadolinium enhanced imaging and 10 healthy volunteers. In parallel, 6 myosin binding protein C3-knock-in and 6 wild-type mice (7-8 weeks) underwent cine-cardiovascular magnetic resonance imaging (9.4 T), ex vivo cDTI, scanning electron microscopy, and histology for microstructural, collagen area fraction and fibrosis analysis. HCM patients exhibited reduced FA vs controls (0.29 ± 0.03 vs 0.34 ± 0.02; P = 0.002), correlating with strain impairment (R2 = 0.67; P = 0.003) and reaching the lowest value in patients with late gadolinium enhancement (P = 0.02). In knock-in mice, the reduction in FA mirrored the human findings. However, additional alterations were observed, including elevated HA transmurality, significant systolic dysfunction, and a strong correlation between FA and interstitial fibrosis. FA may reflect critical aspects of myocardial remodeling in HCM, including fibrosis, and mechanical dysfunction, as demonstrated in both preclinical and clinical settings. Its ability to detect abnormalities even in patients with preserved ejection fraction supports its potential as a translational marker for risk stratification and guiding therapeutic intervention.

1 October 2026 in Bioactive Materials
Verified
Journal Article
Open access
MBMostafa Berangi
Mostafa Berangi
HWHelmar Waiczies
Helmar Waiczies
Nandita SahaNandita Saha
Nandita Saha
SSShahriar Shalikar
Shahriar Shalikar
MMMahsa Salimi Majd
Mahsa Salimi Majd
Thoralf NiendorfThoralf Niendorf
Thoralf Niendorf
Magnesium (Mg) alloy screws represent promising biodegradable orthopedic implants owing to their biocompatibility, mechanical strength, and gradual resorption, thereby obviating the need for secondary removal surgery. However, their electrical conductivity raises safety concerns during magnetic resonance imaging (MRI) used for the assessment of healing progress and potential complications, where exposure to radiofrequency (RF) energy may induce tissue heating. As Mg implants degrade, evolving geometry and material phase may alter electromagnetic behavior, deposition of RF energy and potential heating. This study systematically examined the effects of key degradation mechanisms—volume reduction, surface roughening, formation of a magnesium hydroxide layer, and implant fractures—on MRI-induced heating. High-resolution electromagnetic field simulations at 3.0 T (ASTM F2182 phantom and realistic human voxel model) were complemented by thermal modeling and experimental MRI heating measurements using real-world screws. Volume loss and edge smoothing reduced maximum 1g-specific absorption rate (SAR1g) by up to 12%, while surface roughness (RMS = 0.5 mm) reduced SAR1g by −0.28% through increased surface impedance. Degradation layer caused minimal SAR change (<0.5%). Screw fractures increased localized SAR1g by up to 19.1% but redistributed heat more uniformly across the implant, lowering peak temperatures compared to intact screws. In the human voxel model, fractured screws remained below the IEC safety limits under maximum permissible RF exposure with a maximum temperature elevation of 38.9 °C, whereas non-fractured screws exceeded 40 °C. Our results demonstrate that Mg screw degradation generally mitigates MRI heating risks. In conclusion, engineered degradation features may enhance MRI safety, providing design guidance for next-generation biodegradable orthopedic implants.

18 June 2026 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
JVJose Raul Velasquez Vides
Jose Raul Velasquez Vides
CHCarl Julius Jacob Herrmann
Carl Julius Jacob Herrmann
TGThomas Gladytz
Thomas Gladytz
HHHoby P. Hetherington
Hoby P. Hetherington
HMHendrik Mattern
Hendrik Mattern
Thoralf NiendorfThoralf Niendorf
Thoralf Niendorf
Purpose: To demonstrate the synergy of undersampled radial 2in1‐RARE‐EPI acquisition and nonlinear model‐based reconstruction for accelerated and simultaneous T 2 , T 2 *, and R 2 ′ mapping in brains of patients with multiple sclerosis (MS). Methods: 2in1‐RARE‐EPI combines a RARE module with an EPI module to capture T 2 and T 2 * information. Nonlinear model‐based reconstruction was applied to estimate T 2 , T 2 * maps directly from undersampled k ‐space data. A retrospective undersampling experiment was conducted to compare nonlinear model‐based and parallel imaging compressed sensing (PICS) reconstruction. The proposed approach was validated and compared to reference methods multiecho spin‐echo ( T 2 , MSE) and multiecho gradient‐echo ( T 2 *, MGRE) in a phantom, healthy subjects, and MS patients. Results: 2in1‐RARE‐EPI together with nonlinear model‐based reconstruction enabled T 2 , T 2 *, and R 2 ′ mapping with 7.5‐fold scan‐time acceleration relative to the references, while addressing key limitations of reference techniques, including long acquisition times, misregistration, motion and off‐resonance sensitivity, and the need for calibration scans. Phantom and in vivo validation showed that the parametric maps obtained with this approach were in agreement with the reference methods. Compared with PICS, nonlinear model‐based reconstruction showed more consistent spatial detail and accuracy at higher acceleration factors. The proposed method detected small focal lesions in T 2 , T 2 *, and R 2 ′ maps of MS patients and enabled visualization of the central vein sign. Conclusion: Scan time reduction facilitated by nonlinear model‐based reconstruction of 2in1‐RARE‐EPI provides a technical foundation for enhanced patient compliance, and is a fundamental precursor for broader clinical studies on the potential of T 2 , T 2 *, and R 2 ′ as imaging biomarkers.

14 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
OLOumaima Laghzali
Oumaima Laghzali
SSShahriar Shalikar
Shahriar Shalikar
SLSiqin Liu
Siqin Liu
SLSandra Lehmann
Sandra Lehmann
JPJoao dos Santos Periquito
Joao dos Santos Periquito
MKMin-Chi Ku
Min-Chi Ku
Background/Objectives: While T2* mapping effectively assesses cerebral blood oxygenation, its utility for capturing cardiac phase-dependent myocardial changes in hypertrophic cardiomyopathy (HCM) is underexplored. This study investigates T2* dynamics in an HCM mouse model, to validate T2* as a clinically relevant biomarker for improved HCM diagnosis and treatment monitoring. Methods: A cardiac-specific Mybpc3 genetic mouse model, closely mirroring human HCM, was used with 12 young mice (6–11 weeks old), including both male and female wild-type (WT) and Mybpc3-KI (HCM) groups. The cardiac function was assessed using self-gated multi-slice 2D CINE imaging. To investigate myocardial T2* variations across the cardiac cycle, multi-gradient echo (MGE) imaging was employed. This approach used retrospective gating and continuous acquisition synchronization with pulse oximetry at 9.4 T small animal MRI. Results: Mybpc3-KI mice demonstrated left-ventricular (LV) hypertrophy compared to WT (HCM = 50.08 ± 4.68 µm/g vs. WT = 45.80 ± 20.07 µm/g, p < 0.01) and reduced ejection fraction (HCM = 38.55 ± 5.39% vs. WT= 72.53 ± 3.95%, p < 0.01). Myocardial T2* was significantly elevated in HCM across all cardiac phases (HCM = 12.14 ± 1.54 ms vs. WT = 7.93 ± 1.57 ms, p = 0.002). Strong correlations were observed between myocardial T2* and LV mass (rho = 0.88, p = 0.03). Conclusions: T2* was elevated in HCM with increased LV mass, highlighting the potential of T2* MRI as a sensitive biomarker for distinguishing healthy mice from those with HCM and revealing possible myocardial abnormalities.